pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Bicillin L A
Bicillin L A (penicillin G benzathine)
Upper Respiratory Tract Infections by Streptococcus pyogenes
$PFEPFIZER INC
0 catalysts
Phase 1
CB-06036
Hepatitis B
$GSKGSK plc
0 catalysts
Phase 2
CDI-988
Norovirus Infections
$COCPCocrystal Pharma, Inc.
0 catalysts
Phase 1
← prev
page 7 of 24
next →
131
Pain89
Neurology1
CK-0802
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Cellenkos Inc
0 catalysts
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
0 catalysts
Phase 2
COVID-19 (S Protein)
Coronavirus Disease 2019 (COVID-19)
$VXRTVaxart, Inc.
0 catalysts
pre_registration
COVID-19 (omicron JN.1) vaccine
Covid-19 (Omicron JN.1) Vaccine
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Phase 3
COVID/Influenza Combination Vaccine
Seasonal Influenza
$NVAXNOVAVAX INC
0 catalysts
Phase 2
CRS-3123
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Methionine--tRNA ligase
Crestone Inc
0 catalysts
Preclinical
CSA-CFI
Pseudomonas aeruginosa Infections
Kinnear Pharmaceuticals LLC
0 catalysts
Phase 1
CSL-404
Pandemic Influenza
$CSLLYCSL LTD
0 catalysts
Preclinical
CTX-002
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Ceria Therapeutics Inc
0 catalysts
Preclinical
CTX-187
Gram-Negative Bacterial Infections
Centauri Therapeutics Ltd
0 catalysts
Preclinical
CVX-20733
Coronavirus Disease 2019 (COVID-19)
Covirix Medical Pty Ltd
0 catalysts
Preclinical
CVX-20799
Coronavirus Disease 2019 (COVID-19)
Covirix Medical Pty Ltd
0 catalysts
Phase 2
CampETEC
Campylobacter Infections
$IMRNImmuron Ltd
0 catalysts
Phase 1
Campylobacter jejuni [strain CPS81-176] vaccine
Campylobacter Infections
US Army Medical Research & Materiel Command
0 catalysts
Phase 1
CodaVax-RSV
Respiratory Syncytial Virus (RSV) Infections
Codagenix Inc
0 catalysts
Marketed
Comirnaty KP.2
Omicron KP.2-adapted monovalent COVID-19 vaccine
Coronavirus Disease 2019 (COVID-19)
BioNTech US Inc
0 catalysts
Marketed
Comirnaty LP.8.1
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Phase 3
Coronavirus Disease 2019 (COVID-19) + influenza vaccine
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Marketed
Coronavirus Disease 2019 (COVID-19) KP.2 vaccine
Spikevax KP.2
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Marketed
Coronavirus Disease 2019 (COVID-19) vaccine 1
Covid-19 Vaccine (mivalsecovatein [INN])
Coronavirus Disease 2019 (COVID-19)
$NVAXNOVAVAX INC
0 catalysts
Preclinical
Coronavirus Disease 2019 (COVID-19) vaccines
Coronavirus Disease 2019 (COVID-19)
University of Florida
0 catalysts
Marketed
Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
Spikevax Omicron XBB.1.5
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Marketed
Cyfendus
Anthrax
$EBSEmergent BioSolutions Inc.
0 catalysts
Preclinical
Cyto-111
Botulism
CytoDel Inc
0 catalysts
Phase 1
D-121
Visceral Leishmaniasis (Kala-Azar)
Oblita Therapeutics BVBA
0 catalysts
Phase 3
DAS-181
Human Parainfluenza Virus 3 Infections
Ansun Biopharma Inc
0 catalysts
Preclinical
DCOY-102
Coronavirus Disease 2019 (COVID-19)
$DCOYDecoy Therapeutics Inc.
0 catalysts